Harvard Bioscience, Inc.
HBIO
$7.08
$0.111.58%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -12.62% | 27.98% | 109.69% | 49.20% | 83.84% |
| Total Receivables | 21.47% | 8.11% | 7.92% | -5.63% | -4.40% |
| Inventory | -0.11% | -2.68% | -10.50% | -16.88% | -11.44% |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -3.15% | 17.74% | -4.66% | -3.70% | -30.03% |
| Total Current Assets | 3.32% | 5.74% | 6.89% | -6.38% | -3.15% |
|
|
|||||
| Total Current Assets | 3.32% | 5.74% | 6.89% | -6.38% | -3.15% |
| Net Property, Plant & Equipment | -2.47% | -5.64% | 6.42% | 6.35% | 31.23% |
| Long-term Investments | -8.10% | 4.60% | -83.03% | -83.42% | -82.07% |
| Goodwill | -8.10% | 4.60% | -83.03% | -83.42% | -82.07% |
| Total Other Intangibles | -31.94% | -31.83% | -31.38% | -32.10% | -32.01% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -33.33% | -26.59% | -5.08% | 29.72% | 18.33% |
| Total Assets | -4.75% | -2.33% | -36.77% | -40.57% | -37.87% |
|
|
|||||
| Total Accounts Payable | 31.81% | 9.96% | -23.71% | -2.03% | -17.32% |
| Total Accrued Expenses | -2.58% | 12.95% | 57.46% | -14.43% | 2.65% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -95.60% | -95.85% | -96.00% | 649.06% | 660.09% |
| Total Finance Division Other Current Liabilities | 25.42% | 30.29% | 34.99% | 14.25% | 20.88% |
| Total Other Current Liabilities | 25.42% | 30.29% | 34.99% | 14.25% | 20.88% |
| Total Current Liabilities | -55.09% | -57.08% | -60.04% | 139.09% | 144.03% |
|
|
|||||
| Total Current Liabilities | -55.09% | -57.08% | -60.04% | 139.09% | 144.03% |
| Long-Term Debt | 83,268.18% | -- | 36,132.32% | -- | -99.86% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -15.31% | -12.05% | 7.85% | 9.33% | 48.46% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -30.70% | -31.60% | -12.92% | 10.63% | -10.71% |
| Total Liabilities | 7.00% | 4.50% | 4.79% | -3.02% | 4.37% |
|
|
|||||
| Common Stock & APIC | 1.16% | 1.24% | 1.31% | 0.83% | 1.16% |
| Retained Earnings | -4.94% | -4.70% | -35.88% | -34.07% | -37.46% |
| Treasury Stock & Other | -5.75% | 14.26% | 25.51% | 4.76% | 21.29% |
| Total Common Equity | -52.85% | -32.28% | -78.32% | -78.46% | -76.60% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -52.85% | -32.28% | -78.32% | -78.46% | -76.60% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -52.85% | -32.28% | -78.32% | -78.46% | -76.60% |
|
|
|||||